分化型甲状腺癌手术中应用纳米碳混悬注射液的效果分析

doi:10.3969/j.issn.1009-976X.2024.03.006

摘要/Abstract

摘要： 目的分析分化型甲状腺癌患者手术中应用纳米碳混悬注射液的治疗效果。方法回顾性收集2021年1月至2023年12月河北省承德市中心医院收治的92例行甲状腺全切+单侧中央区淋巴清扫术患者的临床资料,根据治疗方法不同分为纳米碳组（纳米碳混悬注射液治疗,n=46）和对照组（常规手术治疗,n=46）,比较两组治疗效果。结果纳米碳组的颈部淋巴结清扫个数（6.37±4.44）多于对照组（t=3.919,P<0.001）,颈部淋巴结转移的检出率（56.5%）高于对照组（χ²=10.172,P=0.001）,甲状旁腺误切率（6.5%）低于对照组（χ²=4.389,P=0.036）。纳米碳组术后7 d内低钙症状发生率（8.7%）低于对照组（χ²=4.842,P=0.028）,且术后7 d内总的相关并发症发生率（13.0%）低于对照组（χ²=5.974,P=0.015）。结论分化型甲状腺癌患者手术中应用纳米碳混悬注射液,能够提高颈部淋巴结转移的检出率,增加颈部淋巴结清扫个数以及降低甲状旁腺的误切率,还可以降低患者术后7 d内相关并发症的发生率,并对降低患者术后7 d内低钙症状的发生率有显著影响。

关键词: 分化型甲状腺癌, 纳米碳混悬注射液, 淋巴结清扫个数, 甲状旁腺, 并发症

Abstract: Objective To analyze Analysis of the effect of intraoperative application of nanocarbon-mixed injection in patients with differentiated thyroid cancer. Methods The clinical data of 92 cases of patients with total thyroidectomy + unilateral central zone lymphatic dissection admitted to Chengde City Central Hospital in Hebei Province from January 2021 to December 2023 were retrospectively collected and divided into the nanocarbon group （nanocarbon suspension injection treatment, n=46） and the control group （conventional surgical treatment, n=46） according to the different treatment methods. The treatment effects of the two groups were compared. Results The number of cervical lymph nodes cleared in the nanocarbon group （6.37±4.44） was more than that in the control group （t=3.919, P<0.001）. The rate of cervical lymph node metastasis （56.5%） was higher than that of the control group （χ²=10.172, P=0.001）, and the misdissection of parathyroid gland rate （6.5%） was lower than that of the control group （χ²=4.389, P=0.036）. The incidence of hypocalcemic symptoms in the nanocarbon group within 7 d postoperatively （8.7%） was lower than that in the control group （χ²=4.842, P=0.028）, and the incidence of total associatedcomplications in the postoperative period within 7 d （13.0%） was lower than that in the control group （χ²=5.974, P=0.015）. Conclusion The intraoperative application of nanocarbon-mixed injection in patients with differentiated thyroid cancer was able to improve the detection rate of cervical lymph node metastasis, increase the number of cervical lymph nodes cleared as well as reduce the rate of misdissection of the parathyroid glands, and also reduce the incidence of complications related to the patients in the postoperative period of 7 d. It also had a significant impact on the reduction of the incidence of hypocalcemic symptoms in the patients within seven days after surgery.

Key words: differentiated thyroid cancer, nanocarbon suspension injection, number of lymph node dissection, parathyroid glands, complications

中图分类号:

R736.1

张杨毅, 丁珞洲, 雒虹郦, 刘策, 任佳, 马胜辉. 分化型甲状腺癌手术中应用纳米碳混悬注射液的效果分析[J]. 岭南现代临床外科, 2024, 24(03): 183-186.

ZHANG Yang-yi, DING Luo-zhou, LUO Hong-li, LIU Ce, REN Jia, MA Sheng-hui. Exploration of the effect of applying nanocarbon suspension injection in thyroid cancer surgery[J]. Lingnan Modern Clinics In Surgery, 2024, 24(03): 183-186.

参考文献

[1] Zheng R, Zhang S, Zeng H, et al.Cancer incidence and mortality in China, 2016[J]. J Nat Cancer Center, 2022, 2(1): 1-9.
[2] 王少明, 郑荣寿, 韩冰峰, 等. 2022年中国人群恶性肿瘤发病与死亡年龄特征分析[J]. 中国肿瘤, 2024, 33(3): 165-174.
[3] 中华医学会内分泌学分会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J]. 中华内分泌代谢杂志, 2023, 39(3): 181-226.
[4] 徐磊, 周鹏, 庄大勇, 等. 甲状旁腺自体荧光联合纳米碳在甲状腺癌术中应用[J]. 中华内分泌外科杂志, 2023, 17(1): 19-23.
[5] Shi C, Tian B, Li S, et al.Enhanced identification and functional protective role of carbon na anoparticles on parathyroid in thyroid cancer surgery: A retrospective Chinese population study[J]. Medicine (Baltimore), 2016, 95(46): e5148.
[6] 朱江, 那将超, 田国标, 等. 纳米炭在甲状腺乳头状癌淋巴结清扫中的价值及对术后甲状旁腺激素的影响[J]. 中国耳鼻咽喉头颈外科, 2022, 29(3): 141-145.
[7] 张浩, 项敬哲, 孙威. 分化型甲状腺癌的复发治疗[J]. 西安交通大学学报(医学版), 2024, 45(1): 23-27.
[8] 曹琳, 陈晓红. 甲状腺手术中下位甲状旁腺的位置及其临床意义[J]. 中国眼耳鼻喉科杂志, 2022, 22(2): 124-126+136.
[9] Liu X, Shi Ch, Jiang XL, et al.Identifying Parathyroid Glands With Carbon Nanoparticle Suspension Does Not Help Protect Parathyroid Function in Thyroid Surgery: A Prospective, Randomized Control Clinical Study[J]. Surg Innov, 2016, 23(4): 381-389.
[10] Asari R, Passler C, Kaczirek K, et al.Hypoparathyroidism after total thyroidectomy: a prospective study[J]. Arch Surg, 2008, 143: 132-137.
[11] 李朝军, 殷向党, 张哲, 等. 纳米炭混悬注射液在甲状腺癌中央区淋巴结清扫术中的应用效果分析[J]. 中国实验诊断学, 2016, 20(7): 1108-1110.
[12] 王新征, 李玉梅, 刘金彪, 等. 纳米碳甲状旁腺淋巴负显影技术在甲状腺癌手术中对甲状旁腺功能的保护作用[J]. 中国实用医药, 2016, 11(12): 48-49.
[13] 苏心娣, 柴芳, 林本瑞, 等. 纳米碳在甲状腺癌手术中的应用[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(1): 12-15.
[14] 谢天皓, 哈思宁, 张景, 等. 纳米碳混悬液在甲状腺癌手术中对甲状旁腺功能保护的应用价值[J]. 中国现代普通外科进展, 2021, 24(2): 125-127.
[15] 王岩. 纳米碳示踪技术在甲状腺癌患者手术中应用效果探讨[J]. 系统医学, 2023, 8(20): 14-17.
[16] 乔菲菲, 吴雨雷. 纳米碳在甲状腺癌手术中对甲状旁腺及喉返神经的保护作用[J]. 中国药物与临床, 2021, 21(5): 800-802.